MeSH tree: E01
A novel AI model can use information collected during routine sleep studies to identify patients' long-term health risks, according to a new study published in Nature Communications. Developed by a multidisciplinary research ...
Aug 3, 2026
0
13
A Singapore team of clinician-scientists and researchers has developed a new tool that accurately predicts which liver cancer patients are likely to experience a recurrence after surgery. The machine-learning tool combines ...
Aug 3, 2026
0
9
Infants use eye contact with speakers to work out what to pay attention to and synchronize their brainwaves, helping them learn language, scientists in Cambridge and Singapore have shown.
Aug 1, 2026
0
21
Screening for eosinophilic esophagitis (EoE) in a pediatric asthma clinic may identify more patients than previously thought, according to a study published online June 23 in The Journal of Allergy and Clinical Immunology: ...
Jul 30, 2026
0
5
Patients with deficient DNA mismatch repair (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer experienced a 58% reduction in the risk of disease progression or death when treated with atezolizumab ...
Jul 30, 2026
0
8
Many people who survive a heart attack will later develop heart failure due to the scarring that occurs as the heart heals. Researchers at Uppsala University are now presenting a new type of biological treatment that is administered ...
Jul 30, 2026
0
8
A new study from Reichman University has found that a short, three-week digital training program, combined with standard drug treatment for Parkinson's disease, led to significant improvements in patients' motor function ...
Jul 30, 2026
0
14
A research team from The Hong Kong University of Science and Technology (HKUST) has developed a novel AI framework, the Generalist–Specialist Collaboration (GSCo), which enables a generalist foundation model and specialist ...
Jul 30, 2026
0
6
Women who test negative for BRCA gene mutations may still be at greater risk of developing breast cancer than the general population, according to a study led by Cedars-Sinai Health Sciences University investigators.
Jul 30, 2026
0
12
A combination of two immunotherapy drugs showed encouraging activity when added to standard chemotherapy given before surgery for patients with high-risk, early-stage HER2-negative breast cancer, according to Phase II clinical ...
Jul 30, 2026
0
11
